课题基金 / 基金详情

Sequence analysis of X ray-induced and anticancer drug-induced mutations in cultured mammalian cells and peripheral blood lymphocytes

Sequence analysis of X ray-induced and anticancer drug-induced mutations in cultured mammalian cells and peripheral blood lymphocytes
X射线诱导和抗癌药物诱导的培养哺乳动物细胞和外周血淋巴细胞突变的序列分析
批准号:
07670992
负责人:
KIMURA Hiroshi
金额:
$1.47万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

KIMURA Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Anticancer drugs and environmental carcinogens sometimes cause a particular type of change in DNA base sequence. This type of change is useful to estimate the risk of cancer incidence of those who are exposed to these chemicals, as the change, if found, can be attributed to results of the exposure to these chemicals. The neocarzinostatin (NCS)-induced mutations were studied using cultured CHO cells, to determine if there is such a particular change. We found a variety of class of mutations (deletions, small deletions, frameshifts and base changes) in NCS-induced mutations. The rate of these classes of multations were quite similar to that of mutations arising spontaneously, suggesting that underlying mechanism may share to some extent in both mutations. On the other hand, a characteristic change was found in base change type of mutations in NCS-treated cells. The some of changed bases were at mutation site where there is AGC or ACT sequence, which was not found in mutations arising spontaneously. It is well known using oligonucleotide that NCS binds to DNA by intercalation so that these specific sequences are targeted. These findings would be helpful, when researchers want to identify whether or not mutations in oncogene or tumor suppressor gene in seocndary tumor are caused by NCS,an anticancer durg used for cancer treatment. The NCS-induced mutations in lymphocytes are now being underway.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Ikebuchi, M: "Are three forms of potentially lethal damage expressed after X irradiation by treatment with hypertonic solution in Chinese hamster V79 cells?" Radiat. Res.141. 19-27 (1995)
Ikebuchi, M:“在中国仓鼠 V79 细胞中,用高渗溶液处理 X 射线后,是否会表现出三种形式的潜在致命损伤?”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kimura,H.: "The scid mutation does not affect slowly repairing potentially lethal damage that is sensitive to 0.23 M NaCl" J.Radiat.Res.37. 247-255 (1997)
Kimura,H.:“scid 突变不会影响对 0.23 M NaCl 敏感的潜在致命损伤的缓慢修复”J.Radiat.Res.37。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ogawa, H.et al.: "Spectrum of Co(II)-induced mutations in supF gene in E.coli" Kankyo Hen-igen Kenkyu. 16. 391-396 (1995)
Okawa, H.et al.:“大肠杆菌中 Co(II) 诱导的 suF 基因突变谱”Kankyo Hen-igen Kenkyu。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
15
    Cell therapy against intractable EB virus infection using immunological tolerance
    • 批准号:
      24659493
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      KIMURA Hiroshi
    • 依托单位:
    An on-chip hepatic metabolism model for pharmacokinetic studies
    • 批准号:
      24710141
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.91万
    • 财政年份:
      2012
    • 负责人:
      KIMURA Hiroshi
    • 依托单位:
    The decreases in hypoxic ventilatory response affect acute exacerbation in patients with respiratory failure and/or obesity hypoventilation syndrome
    • 批准号:
      23591158
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      KIMURA Hiroshi
    • 依托单位:
    Live cell imaging of histone methylation and inactive X chromosome dynamics
    • 批准号:
      22370063
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2010
    • 负责人:
      KIMURA Hiroshi
    • 依托单位:
    国内基金
    海外基金
    放疗通过激活GSDMD诱发细胞焦亡促进肿瘤再增殖的机制研究及干预策略探讨
    • 批准号:
      82373299
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      程进
    • 依托单位: